Revumenib in Combination With 7+3 + Midostaurin in AML
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to AML
Related studies linked through entity extraction aliases.
Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- NA
Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Combination Salvage Therapy With Venetoclax and Decitabine in Relapsed/Refractory AML
- Status
- RECRUITING
- Phase
- PHASE2
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Status
- RECRUITING
- Phase
- N/A
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
- Status
- TERMINATED
- Phase
- PHASE1
A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS
- Status
- UNKNOWN
- Phase
- PHASE1
Adaptive Treatment for Acute Myeloid Leukemia Based on D14 MRD Results
- Status
- RECRUITING
- Phase
- PHASE2
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
NKG2D CAR-NK & r/rAML
- Status
- UNKNOWN
- Phase
- NA
Drug-screening in AML at Relapse for Targeted Treatment
- Status
- COMPLETED
- Phase
- NA
Psychological Mobile App for Patients With AML
- Status
- TERMINATED
- Phase
- NA
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML
- Status
- UNKNOWN
- Phase
- PHASE1